Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › S1P receptor modulators for treating relasping-remitting multiple sclerosis

S1P receptor modulators for treating relasping-remitting multiple sclerosis

US Patent 9187405 · Granted Nov 17, 2015

Estimated economic value: $12,726,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhi2019
Short interfering ribonucleic acid (siRNA) for oral administration2016
Short interfering ribonucleic acid (siRNA) for oral administration2015
S1P receptor modulators for treating multiple sclerosis2014
S1P receptor modulators for treating multiple sclerosis2014
Short interfering ribonucleic acid (siRNA) for oral administration2013
Short interfering ribonucleic acid (siRNA) for oral administration2013
Short interfering ribonucleic acid (siRNA) for oral administration2013
Organic compounds2012
Short interfering ribonucleic acid (siRNA) with improved pharmacological propert2011
Polymeric matrices and their uses in pharmaceutical compositions2001
Polymeric matrices and their uses in pharmaceutical compositions2000